Skip to Content

535 (Minocycline Hydrochloride Extended-Release 135 mg)

Pill with imprint 535 is Pink, Capsule-shape and has been identified as Minocycline Hydrochloride Extended-Release 135 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..

Minocycline is used in the treatment of bacterial infection; acne; bartonellosis; actinomycosis; bullous pemphigoid and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Minocycline 135 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 535

Minocycline Hydrochloride Extended-Release

Imprint
535
Strength
135 mg
Color
Pink
Size
16.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Tetracyclines
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals (USA) Inc.
Manufacturer
Cadila Healthcare Limited
National Drug Code (NDC)
70771-1167
Inactive Ingredients
D&C Red No. 27, D&C Yellow No. 10, FD&C Blue No. 2, hypromelloses, lactose monohydrate, magnesium stearate, polyethylene glycol 3350, silicon dioxide, titanium dioxide, triacetin

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "535"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.